POS1197 IN DEPTH IDENTIFICATION OF RISK FACTORS FOR SEVERE COVID-19, REQUIRING HOSPITALIZATION, IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: RESULTS OF A DUTCH NESTED CASE CONTROL STUDY (PRELIMINARY RESULTS)

Background: Several risk factors for severe COVID-19 have been identified 1 . An important question is whether in addition to these generic risk factors, patients with a potentially altered immune response, either by disease (inflammatory rheumatic diseases (IRDs)) or use of immunomodulatory agents (IA), carry a higher or lower risk of severe COVID-19. In addition, several other potential risk factors for severe COVID-19 have been suggested, such as vitamin D status and specific medication (NSAIDs, ACE-inhibitors) 2 . Objectives: To identify risk factors for severe COVID-19, requiring hospital... Mehr ...

Verfasser: Opdam, M.
Benoy, S.
Verhoef, L. M.
Van Bijnen, S.
Lamers-Karnebeek, F.
Traksel, R. A. M.
Vos, P.
Den Broeder, A.
Broen, J.
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Reihe/Periodikum: Annals of the Rheumatic Diseases ; volume 80, issue Suppl 1, page 880.2-881 ; ISSN 0003-4967 1468-2060
Verlag/Hrsg.: BMJ
Schlagwörter: General Biochemistry / Genetics and Molecular Biology / Immunology / Immunology and Allergy / Rheumatology
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26649683
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://dx.doi.org/10.1136/annrheumdis-2021-eular.1853